Area of research
Oncology · Hepatology
Research interest
Research interests include Hepatocellular Carcinoma Treatment and Prognosis, Cancer Immunotherapy and Biomarkers, Pancreatic and Hepatic Oncology Research, and Cholangiocarcinoma and Gallbladder Cancer Studies.
Personalized prediction of postoperative complication and survival among Colorectal Liver Metastases Patients Receiving Simultaneous Resection using machine learning approaches: A multi-center study
Chinese Expert Consensus on the Whole-Course Management of Hepatocellular Carcinoma (2023 Edition)
Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)
Nomogram for tumour response based on prospective cohorts of hepatocellular carcinoma patients receiving immunotherapy combined with targeted therapy: development and validation
Chinese expert consensus on multidisciplinary diagnosis and treatment of pancreatic neuroendocrine liver metastases
Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition)
Chinese Expert Consensus on Immunotherapy for Hepatocellular Carcinoma (2021 Edition)
Anlotinib Monotherapy for Refractory Metastatic Colorectal Cancer: A Double-Blinded, Placebo-Controlled, Randomized Phase III Trial (ALTER0703)
Evaluation of thyroid-stimulating hormone-increased, hypertriglyceridemia and proteinuria as markers of anlotinib efficacy in advanced soft tissue sarcoma.
Efficacy of anlotinib in advanced soft tissue sarcoma by age, gender, and ECOG performance status.
Effect of Huaier granule on recurrence after curative resection of HCC: a multicentre, randomised clinical trial
Chinese guidelines for the diagnosis and comprehensive treatment of colorectal liver metastases (version 2018)
Anlotinib for metastasis soft tissue sarcoma: A randomized, double-blind, placebo-controlled and multi-centered clinical trial.
Phase III HEAT Study Adding Lyso-Thermosensitive Liposomal Doxorubicin to Radiofrequency Ablation in Patients with Unresectable Hepatocellular Carcinoma Lesions
Phase II study of anlotinib for treatment of advanced soft tissues sarcomas.